MedTrace Logo

The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular Carcinoma

NCT02525965 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 194

Last updated 2016-03-31

No results posted yet for this study

Summary

Before the surgery, the investigators predict the risk of microvascular invasion (MVI) presence for the early-stage hepatocellular carcinoma according to the nomogram the investigators have created. Patients with a high risk of microvascular invasion were randomly chose to give the treatment of a wide resection margin, which establish an individualized anti-recurrence program based on the high-grade evidence-based medicine.

Conditions

Interventions

PROCEDURE

Wide resection margin >1cm

Surgical removal of lesions choosing the method of wide resection margin \>1cm

PROCEDURE

Narrow resection margin <1cm

Surgical removal of lesions choosing the method of wide resection margin \<1cm

Sponsors & Collaborators

  • Eastern Hepatobiliary Surgery Hospital

    lead OTHER

Principal Investigators

  • Shen Feng, MD · Eastern Hepatobiliary Surgery Hospital, Second Military Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02525965 on ClinicalTrials.gov